This content is from: Patents

Arthrex could make 'political animal' of USPTO head say in-house

SCOTUS's preservation of the PTAB came as a relief to many counsel, but its fix has raised concerns about political lobbying and the procedure for final review

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial